1655 studies found for:    Open Studies | "Kidney Diseases"
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Recruiting Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease
Conditions: Chronic Kidney Disease;   Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan (OPC-41061);   Drug: Placebo
2 Recruiting New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease
Conditions: Autosomal Dominant Polycystic Kidney Disease;   Kidney Disease
3 Recruiting Repository Study of Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
4 Recruiting Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)
Condition: Polycystic Kidney Disease
Interventions: Dietary Supplement: Niacinamide;   Other: Placebo
5 Recruiting Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease
Conditions: Chronic Renal Failure;   Polycystic Kidney Disease
Intervention: Biological: Intravenous injection autologous mesenchymal stem cells
6 Recruiting Lanreotide In Polycystic Kidney Disease Study
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD
Interventions: Drug: Lanreotide;   Drug: saline
7 Recruiting The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Everolimus;   Drug: Calcineurin inhibitors maintenance
8 Unknown  Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients
Conditions: Chronic Kidney Disease Stage 4;   Chronic Kidney Disease Stage 3
Intervention: Drug: Aspirin
9 Recruiting Improving Evidence-Based Primary Care for Chronic Kidney Disease
Conditions: Chronic Kidney Disease;   Chronic Kidney Insufficiency;   Chronic Renal Diseases;   Chronic Renal Insufficiency;   Kidney Insufficiency, Chronic
Interventions: Other: Facilitated Clinical Decision Support;   Other: Clinical Decision Support Only
10 Recruiting Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5
Conditions: End-Stage Renal Disease;   Stage 5 Chronic Kidney Disease
Interventions: Drug: Telavancin;   Procedure: Pharmacokinetic Blood Sampling
11 Recruiting Polycystic Kidney Disease Data Repository
Condition: Polycystic Kidney Disease
12 Recruiting Pyridorin in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Diabetic Kidney Disease
Interventions: Drug: Pyridorin;   Drug: Placebo
13 Recruiting Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
Conditions: Diabetic Nephropathy;   Diabetes Mellitus;   Diabetic Kidney Disease;   Albuminuria
14 Unknown  Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration
Conditions: Diabetic Nephropathy;   Chronic Kidney Disease
Intervention: Drug: Mycophenolate Mofetil (MMF) ,phosphodiesterase 5 inhibitors , CARNITINE
15 Recruiting Triptolide-Containing Formulation as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Interventions: Drug: Triptolide-Containing Formulation;   Drug: Placebo
16 Not yet recruiting Novel Stromal Cell Therapy for Diabetic Kidney Disease
Condition: Diabetic Kidney Disease
Interventions: Biological: Mesenchymal Stromal Cells;   Other: Placebo
17 Unknown  Impact of Vitamin D on Diabetic Kidney Disease in African Americans
Condition: Diabetic Kidney Disease
Intervention: Drug: Vitamin D3
18 Recruiting Using a Diabetic Kidney Disease (DKD) Registry to Treat to Multiple Targets (TMT)
Condition: Diabetic Kidney Disease
Interventions: Other: Telephone Reminder;   Other: Doctor-Nurse Follow Up;   Other: Personalized Risk Report for Patient Empowerment
19 Recruiting Evaluation of Gut Bacteria in Patients With Polycystic Kidney Disease
Condition: Polycystic Kidney Disease
20 Recruiting Pilot Study of Velcade® in IgA Nephropathy
Conditions: Chronic Kidney Disease;   IgA Nephropathy
Intervention: Drug: Bortezomib (Velcade®)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years